Pigmentary Disorders Exchange Symposium
Loews Chicago Hotel
Chicago, Illinois
June 11 - 12, 2027
The 5th Annual Pigmentary Disorders Exchange (PDE) Symposium brings together world‑renowned dermatology experts for an in‑depth exploration of skin pigmentation, including the long‑term pigmentary sequelae that follow inflammatory skin conditions such as acne, atopic dermatitis, psoriasis, and related dermatoses.
Overview
Practical, Clinically Relevant Pigmentation Education for Every Dermatology Clinician
Over two days, faculty will cover pathogenesis, clinical presentation, and cutting‑edge treatment strategies for primary pigmentation conditions (e.g., melasma, vitiligo), congenital presentations, acquired dermal macular hyperpigmentation, and secondary pigmentary outcomes such as post‑inflammatory hyperpigmentation, hypopigmentation, and photodamage, across the full spectrum of skin types.
Join Symposium Chair Pearl E. Grimes, MD, FAAD, for this unique CME/CE event presented by MedscapeLIVE! in partnership with the producers of ODAC Dermatology Conference and Skin of Color Update.
Why Attend?
PDE 2027 goes beyond a surface review. This symposium equips clinicians with practical knowledge and tools to improve treatment outcomes, reduce pigmentary complications, and lessen the long‑term impact of pigmentation issues on patients’ quality of life.
Core themes include
The real‑world impact of pigmentation on patient quality of life and the need for a care‑centered shift in clinical practice.
Pathogenesis and nuanced clinical presentation across conditions from hyperpigmentation to hypopigmentation, with evidence‑based topical, systemic, and procedural strategies.
How therapeutic choices affect pigmentation and how clinicians can optimize regimens to reduce pigmentary complications.
Why Pigmentary Sequelae Matter
Pigmentary conditions, from melasma and vitiligo to post‑inflammatory hyperpigmentation after acne, eczema, or other inflammatory dermatoses, affect patients globally and across all skin types. Because acne is a leading cause of PIH and pigmentation concerns often influence treatment adherence, patient satisfaction, and psychosocial health, PDE 2027 will offer practical treatment strategies clinicians can apply immediately.
Interactive Learning & Networking
This immersive experience will include:
Case‑based discussions
Chemical peels live demonstrations
Thought‑provoking panels
Expert Exchange roundtables
Extended audience Q&A time
Exhibit hall and networking opportunities during the welcome reception and coffee breaks
Meet the Chair
Pearl E. Grimes, MD, FAAD
Clinical Professor of Dermatology
University of California, Los Angeles
Director
The Vitiligo and Pigmentation Institute of Southern California
Director
The Grimes Center for Medical and Aesthetic Dermatology
Los Angeles, California
Early Registration Ends September 15